Back

Heart failure with preserved ejection fraction and incidence rate of atrial fibrillation: insights from a randomized clinical trial

30 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Understanding HFpEF: challenges and insights Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Camilla Ikast Ottosen

Gentofte University Hospital, Copenhagen (Denmark)

6 More presentations in this session

Presentation thumbnail
Functional reserve and prognosis in hypercontractile phenotype patients with heart failure and preserved ejection fraction
Ms Y. WANG (Chengdu, CN)
Abstract Slides Video
Presentation thumbnail
Deciphering human heart failure with preserved ejection fraction (HFpEF) at single cell resolution
Doctor L. Zanders (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
Deep learning-based phenotyping and assessment of treatment responses in heart failure with preserved ejection fraction
Doctor R. Li (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Impact of left ventricular hypercontractility on long-term survival in heart failure with preserved ejection fraction: a pressure-volume loop analysis
Doctor S. Rosch (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Evaluation of left atrial and atrioventricular function in enhanced rat HFpEF models
Doctor Q. Zhang (Chengdu, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Understanding HFpEF: challenges and insights

The Event

Event poster

ESC Congress 2025

30 August 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation and HFpEF: diagnosis and prognosis
thumbnail
Congress Presentation
Atrial fibrillation burden characteristics in heart failure patients with reduced versus preserved ejection fraction as detected by insertable cardiac monitors.
thumbnail
Congress Presentation
Catheter ablation for atrial fibrillation in patients with heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources